Length of survival in hospice for cancer patients referred from a comprehensive cancer center

American Journal of Hospice and Palliative Medicine

Volumn 26, Issue 4, 2009, Pages 281-287

  Younis, Tallal ^a   Milch, Robert ^b   Abul Khoudoud, Nawal ^c   Lawrence, David ^d   Mirand, Amy ^e   Levine, Ellis ^d  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b Center for Hospice and Palliative Care   (United States)

^c Private Practice   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

Author keywords

Cancer; Clinical trial; Hospice; Malignancy; Palliation; Phase I study; Prognosis; Survival

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER CENTER; FEMALE; HEALTH CARE; HOSPICE CARE; HUMAN; KAPLAN MEIER METHOD; KARNOFSKY PERFORMANCE STATUS; LENGTH OF STAY; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASM; ORGANIZATION AND MANAGEMENT; PATIENT REFERRAL; PHASE 1 CLINICAL TRIAL (TOPIC); PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY; SEX RATIO; STATISTICS; SURVIVAL RATE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CANCER CARE FACILITIES; CLINICAL TRIALS, PHASE I AS TOPIC; COMPREHENSIVE HEALTH CARE; FEMALE; HOSPICE CARE; HUMANS; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; NEW YORK; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REFERRAL AND CONSULTATION; REGISTRIES; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 70349116395     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909109333928     Document Type: Article

References (33)

1. Earle CC, Park ER, Lai B., Weeks JC, Ayanian JZ, Block S. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol. 2003; 21:1133-1138.
2. Yabroff KR, Mandelblatt JS, Ingham J. The quality of medical care at the end-of-life in the USA: existing barriers and examples of process and outcome measures. Palliat Med. 2004;18(3):202-216.
3. National Hospice Organization Stats/Research/ Resources: Facts and Figures on Hospice Care in America. http://www.nhpco.org/files/public/2005-facts-and-figures.pdf. Accessed November 10, 2006.
4. General Accounting Office. Medicare: More Beneficiaries Use Hospice but for Fewer Days of Care. Washington, DC: United States General Accounting office; publication No.GAO/HEHS-00-182, 2000. http://www.gao.gov/archive/2000/he00182.pdf. Accessed November 10, 2006.
5. Christakis NA, Iwashyna TJ Attitude and self-reported practice regarding prognostication in a national sample of internists. Arch Intern Med. 1998;158:2389-2395.
6. Social Security Act 1861 (dd)(3)(A). http://www.ssa.gov/OP_Home/ssact/title18/1861.htm#dd3A. Accessed November 10, 2006.
7. Kapo J., Harrold J., Carroll JT, Rickerson E., Casarett D. Are we referring patients to hospice too late? Patients' and families' opinions. J Palliat Med. 2005;8(3):521-527.
8. Rickerson E., Harrold J., Kapo J., Carroll JT, Casarett D. Timing of hospice referral and families' perceptions of services: are earlier hospice referrals better? J Am Geriatr Soc. 2005;53(5):819-823.
9. Casarett DJ, Crowley R., Hirschman KB Surveys to assess satisfaction with end-of-life care: does timing matter? J Pain Symptom Manage. 2003;25(2):128-132.
10. Stillman MJ, Syrjala KL Differences in physician access patterns to hospice care. J Pain Symptom Manage. 1999;17:157-163.
11. Rosenthal MA, Gebski VJ, Kefford RF, et al: Prediction of life expectancy in hospice patients: identification of novel prognostic factors. Palliat Med. 1993;7:199-204.
12. Christakis NA Timing of referral of terminally ill patients to an outpatient hospice. J Gen Intern Med. 1994;9:314-320.
13. Christakis N., Escarce J. Survival of Medicare patients after enrollment in Hospice programs. N Engl J Med. 1996;335:172-178.
14. Christakis NA Predicting patient survival before and after hospice enrollment. Hospice J. 1998;13:71-87.
15. Christakis NA, Iwashyna TJ Impact of individual and market factors on the timing of initiation of hospice terminal care. Med Care. 2000;38:528-541.
16. Casarett DJ Differences between patients referred to hospice from academic vs. non-academic settings. J Pain Symptom Manage. 2001;21:197-203.
17. Virnig BA, Fisher ES, McBean AM, Kind S. Hospice use in Medicare managed care and fee-for-service systems. Am J Manag Care. 2001;7(8):777-786.
18. Virnig BA, McBean M., Kind S., Kind S., Dholakia R. Hospice use before death: variability across cancer diagnoses. Med Care. 2002;40:73-78.
19. Lamont EB, Christakis NA Physician factor in the timing of cancer patient referral to hospice palliative care. Cancer. 2002;94:2733-2737.
20. McCarthy EP, Burns RB, Ngo-Metzger Q., Phillips RS Barriers to hospice care among older patients dying with lung and colorectal cancer. J Clin Oncol. 2003;21: 728-735.
21. McCarthy EP, Burns RB, Ngo-Metzger Q., Davis RB, Phillips RS Hospice use among Medicare managed care and fee-for-service patients dying with cancer. JAMA. 2003;289(17):2238-2245.
22. Younis T., Milch R., Abul-Khoudoud N., Lawrence D., Mirand A., Levine EG Length of survival of cancer patients in hospice: a retrospective analysis of patients treated at a major cancer center versus other practice settings. J Palliat Med. 2007;10(2):381-389.
23. Anderson F., Downing GM, Hill J., Casorso L., Lerch N. Palliative performance scale (PPS): a new tool. J Palliat Care. 1996;12:5-11.
24. Virik K., Glare P. Validation of the palliative performance scale for inpatients admitted to a palliative care unit in Sydney, Australia. J Pain Symptom Manage. 2002;23: 455-457.
25. Harrold J., Rickerson E., Carroll JT, et al. Is the palliative performance scale a useful predictor of mortality in a heterogeneous hospice population? J Palliat Med. 2005;8:503-509.
26. Head B., Ritchie CS, Smoot TM Prognostication in hospice care: can the palliative performance scale help? J Palliat Med. 2005;8:492-502.
27. Lau F., Downing GM, Lesperance M., Shaw J., Kuziemsky C. Use of Palliative Performance Scale in end-of-life prognostication. J Palliat Med. 2006;9(5):1066-1075.
28. Agrawal M., Grady C., Fairclough DL, Meropol NJ, Maynard K., Emanuel EJ Patients' decision-making process regarding participation in phase I oncology research. J Clin Oncol. 2006;24(27):4479-4484.
29. Byock I., Miles SH Hospice benefits and phase I cancer trials. Ann Intern Med. 2003;138:335-337 [comments and authors reply in Ann Intern Med. 2004;140(1):70-71].
30. Casarett DJ, Karlawish JH, Henry MI, Hirschman KB Must patients with advanced cancer choose between a phase I trial and hospice? Cancer. 2002;95(7):1601-1604.
31. Vigano A., Dorgan M., Bruera E., Suarez-Almazor ME The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer. Cancer. 1999;86:170-176.
32. Christakis NA, Lamont EB Extent and determinants of error in doctors' prognoses in terminally ill patients: Prospective cohort study. BMJ. 2000;320:469-473.
33. Chow E., Harth T., Hruby G., Finkelstein J., Wu J., Danjoux C. How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systematic review. Clin Oncol. 2001;15:203-218.